Memory loss in alzheimer's disease

Dialogues in Clinical Neuroscience

Volumn 15, Issue 4, 2013, Pages 445-454

  Jahn, Holger ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Alzheimer's disease; Brain atrophy; Default mode network; Memory; Neuropsychological test

Indexed keywords

ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN ATROPHY; CEREBROSPINAL FLUID; COGNITION; COGNITIVE DEFECT; DECLARATIVE MEMORY; DEFAULT MODE NETWORK; DISEASE ASSOCIATION; EPILEPTIC DISCHARGE; EPISODIC MEMORY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HIPPOCAMPUS; HUMAN; LONG TERM MEMORY; NEUROFIBRILLARY TANGLE; OLFACTORY DISCRIMINATION; SHORT TERM MEMORY; SLEEP; WORKING MEMORY;

ALZHEIMER'S DISEASE; BRAIN ATROPHY; DEFAULT MODE NETWORK; MEMORY; NEUROPSYCHOLOGICAL TEST;

ALZHEIMER DISEASE; BRAIN; COGNITION DISORDERS; HUMANS; MEMORY; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS;

EID: 84893424124     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Wimo A, Jonsson L, Winblad B. An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement Geriatr Cogn Dis. 2006;21:175-181.
2. Hebert LE, Scherr PA, Beckett LA, et al. Age-specific incidence of Alzheimer's disease in a community population. JAMA. 1995;273:1354-1359.
3. Alzheimer A. über eine eigenartige Erkrankung der Hirnrinde. Allgemeine Zeitschrift für Psychiatrie. 1907;64:146-148.
4. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet. 2006;368:387-403.
5. Gerrish A, Russo G, Richards A, et al. The role of variation at A beta PP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. J Alzheimers Dis. 2012;28:377-387.
6. Williams GC. Pleiotropy, natural selection, and the evolution of senescence. Evolution. 1957;11:398-411.
7. Mayeux R. Gene-environment interaction in late-onset Alzheimer disease: the role of apolipoprotein-epsilon4. Alzheimer Dis Assoc Disord. 1998;12(suppl 3):S10-S15.
8. Fullerton SM, Clark AG, Weiss KM, et al. Apolipoprotein E variation at the sequence haplotype level:implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet. 2000;67:881-900.
9. Bufill E, Carbonell E. Apolipoprotein E polymorphism and neuronal plasticity. Am J Hum Biol. 2006;18:556-558.
10. Finch CE, Stanford CB. Meat-adaptive genes and the evolution of slower aging in humans. Q Rev Biol. 2004;79:3-50.
11. Braak H, Braak E. Neurofibrillary changes confined to the entorhinal region and an abundance of cortical amyloid in cases of presenile and senile dementia. Acta Neuropathologica. 1990;80:479-486.
12. Braak H, Braak E. Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis. Acta Neuropathologica. 1996;92:197-201.
13. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathologica. 1991;82:239-259.
14. Hyman BT, Vanhoesen GW, Damasio AR, Barnes CL. Alzheimers-disease - cell-specific pathology isolates the hippocampal formation. Science. 1984;225:1168-1170.
15. Braak H, Del Tredici K, Schultz C, Braak E. Vulnerability of select neuronal types to Alzheimer's disease. Ann N Y Acad Sci. 2000;924:53-61.
16. Bondareff W, Mountjoy CQ, Roth M. Loss of neurons of origin of the adrenergic projection to cerebral cortex (nucleus locus ceruleus) in senile dementia. Neurology. 1982;32:164-168.
17. Mann DM, Yates PO, Marcyniuk B. A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease. J Neurol Neurosurg Psychiatry. 1984;47:201-203.
18. Jacobs HI, Van Boxtel MP, Uylings HB, Gronenschild EH, Verhey FR, Jolles J. Atrophy of the parietal lobe in preclinical dementia. Brain Cogn. 2011;75:154-163.
19. Jacobs HI, Van Boxtel MP, Jolles J, Verhey FR, Uylings HB. Parietal cortex matters in Alzheimer's disease:an overview of structural, functional and metabolic findings. Neurosci Biobehav Rev. 2012;36:297-309.
20. Jacobs HI, van Boxtel MP, Gronenschild EH, et al. Patterns of gray and white matter changes in individuals at risk for Alzheimer's disease. Curr Alzheimer Res. 2012;9:1097-1105.
21. Fox NC, Freeborough PA, Rossor MN. Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet. 1996;348:94-97.
22. Fox NC, Cousens S, Scahill R, Harvey RJ, Rossor MN. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease:power calculations and estimates of sample size to detect treatment effects. Arch Neurol. 2000;57:339-344.
23. Andrews KA, Modat M, Macdonald KE, et al. Atrophy rates in asymptomatic amyloidosis:implications for Alzheimer prevention trials. PLoS One. 2013;8:e58816.
24. Arlt S, Buchert R, Spies L, Eichenlaub M, Lehmbeck JT, Jahn H. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci. 2013;263:335-344.
25. Arlt S, Brassen S, Wilke F, et al. Association between FDG uptake, CSF biomarkers and cognitive performance in patients with probable Alzheimer's disease. Pharmacopsychiatry. 2009;42:210-210.
26. Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC. Posterior cortical atrophy. Lancet Neurol. 2012;11:170-178.
27. Crutch SJ, Schott JM, Rabinovici GD, et al. Shining a light on posterior cortical atrophy. Alzheimers Dement. 2013;9:463-465.
28. Crutch SJ, Lehmann M, Warren JD, Rohrer JD. The language profile of posterior cortical atrophy. J Neurol Neurosurg Psychiatry. 2013;84:460-466.
29. Lehmann M, Crutch SJ, Ridgway GR, et al. Cortical thickness and voxelbased morphometry in posterior cortical atrophy and typical Alzheimer's disease. Neurobiol Aging. 2011;32:1466-1476.
30. Gorno-Tempini ML, Dronkers NF, Rankin KP, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 2004;55:335-346.
31. Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006-1014.
32. Berchtold NC, Coleman PD, Cribbs DH, Rogers J, Gillen DL, Cotman CW. Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease. Neurobiol Aging. 2013;34:1653-1661.
33. Jahn H, Wittke S, Zuerbig P, et al. Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers. Plos One. 2011;6.
34. Zuerbig P, Jahn H. Use of proteomic methods in the analysis of human body fluids in Alzheimer research. Electrophoresis. 2012;33:3617-3630
35. Jessen F, Guer O, Block W, et al. A multicenter H-1-MRS study of the medial temporal lobe in AD and MCI. Neurology. 2009;72:1735-1740.
36. Jack CR, Jr, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dementia. 2011;7:257-262.
37. McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dementia. 2011;7:263-269.
38. Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dementia. 2011;7:280-292.
39. Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dementia. 2011;7:270- 279.
40. Hyman BT, Phelps CH, Beach TG, et al. National Institute on Aging- Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease. Alzheimers Dementia. 2012;8:1-13.
41. Miller GA. The magical number seven, plus or minus two: some limits on our capacity for processing information. Psychol Rev.1956;63:81-97.
42. Verma M, Howard RJ. Semantic memory and language dysfunction in early Alzheimer's disease: a review. Int J Geriatr Psychiatry. 2012;27:1209-1217.
43. Morris JC. Clinical dementia rating:a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type. Int Psychogeriatr. 1997;9(suppl 1):173-176;discussion 177-178.
44. Morris JC, Heyman A, Mohs RC, et al. The consortium to establish a registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39:1159-1165.
45. Morris JC, Mohs RC, Rogers H, Fillenbaum G, Heyman A. Consortium to establish a registry for Alzheimer's disease (CERAD): clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull. 1988;24:641-652.
46. Pepeu G, Giovannini MG. Cholinesterase inhibitors and memory. Chem Biol Interact. 2010;187:403-408.
47. Pepeu G, Giovannini MG, Bracco L. Effect of cholinesterase inhibitors on attention. Chem Biol Interact. 2013;203:361-364.
48. Wagner M, Wolf S, Reischies FM, et al. Biomarker validation of a cued recall memory deficit in prodromal Alzheimer disease. Neurology. 2012;78:379-386.
49. Snigdha S, Milgram NW, Willis SL, et al. A preclinical cognitive test battery to parallel the National Institute of Health Toolbox in humans:bridging the translational gap. Neurobiol Aging. 2013;34:1891-1901.
50. Jessen F, Wiese B, Bachmann C, et al. Prediction of dementia by subjective memory impairment effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry. 2010;67:414-422.
51. Jessen F, Feyen L, Freymann K, et al. Volume reduction of the entorhinal cortex in subjective memory impairment. Neurobiol Aging. 2006;27:1751-1756.
52. Peter J, Scheef L, Abdulkadir A, et al. Gray matter atrophy pattern in elderly with subjective memory impairment. Alzheimers Dement. 2013 Jul 15. [Epub ahead of print].
53. Scheef L, Spottke A, Daerr M, et al. Glucose metabolism, gray matter structure, and memory decline in subjective memory impairment. Neurology. 2012;79:1332-1339.
54. Erk S, Spottke A, Meisen A, Wagner M, Walter H, Jessen F. Evidence of neuronal compensation during episodic memory in subjective memory impairment. Arch Gen Psychiatry. 2011;68:845-852.
55. Striepens N, Scheef L, Wind A, et al. Interaction effects of subjective memory impairment and ApoE4 genotype on episodic memory and hippocampal volume. Psychol Med. 2011;41:1997-2006.
56. Peters JM, Hummel T, Kratzsch T, Lötsch J, Skarke C, Frölich L. Olfactory function in mild cognitive impairment and Alzheimer's disease:an investigation using psychophysical and electrophysiological techniques. Am J Psychiatry. 2003;160:1995-2002.
57. Rahayel S, Frasnelli J, Joubert S. The effect of Alzheimer's disease and Parkinson's disease on olfaction:a meta-analysis. Behav Brain Res. 2012;231:60-74.
58. Palop JJ, Mucke L. Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol. 2009;66:435-440.
59. Palop JJ, Mucke L. Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin? Neuromolecular Med. 2010;12:48-55.
60. Palop JJ, Mucke L, Roberson ED. Quantifying biomarkers of cognitive dysfunction and neuronal network hyperexcitability in mouse models of Alzheimer's disease: depletion of calcium-dependent proteins and inhibitory hippocampal remodeling. Methods Mol Biol. 2011;670:245-262.
61. Harris JA, Devidze N, Verret L, et al. Transsynaptic progression of amyloid- β-induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron. 2010;68:428-441.
62. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci. 2008;1124:1-38.
63. Buckner RL, Snyder AZ, Shannon BJ, et al. Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory. J Neurosci. 2005;25:7709-7717.
64. Herholz K, Salmon E, Perani D, et al. Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET. Neuroimage. 2002;17:302-316.
65. Reiman EM, Caselli RJ, Yun LS, et al. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E. N Engl J Med. 1996;334:752-758.
66. Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC. Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluidregistered serial MRI. Proc Natl Acad Sci U S A. 2002;99:4703-4707.
67. Lustig C, Snyder AZ, Bhakta M, et al. Functional deactivations: change with age and dementia of the Alzheimer type. Proc Natl Acad Sci U S A. 2003;100:14504-14509.
68. Celone KA, Calhoun VD, Dickerson BC, et al. Alterations in memory networks in mild cognitive impairment and Alzheimer's disease:an independent component analysis. J Neurosci. 2006;26:10222-10231.
69. Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging:evidence from functional MRI. Proc Natl Acad Sci U S A. 2004;101:4637-4642.
70. Huijbers W, Pennartz CM, Cabeza R, Daselaar SM. The hippocampus is coupled with the default network during memory retrieval but not during memory encoding. PLoS One. 2011;6:e17463.
71. Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B. Ann Neurol. 2004;55:306- 319.
72. Sheline YI, Morris JC, Snyder AZ, et al. APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42. J Neurosci. 2010;30:17035-17040.
73. Patel KT, Stevens MC, Pearlson GD, et al. Default mode network activity and white matter integrity in healthy middle-aged ApoE4 carriers. Brain Imaging Behav. 2013;7:60-67.
74. Filippini N, MacIntosh BJ, Hough MG, et al. Distinct patterns of brain activity in young carriers of the APOE-epsilon4 allele. Proc Natl Acad Sci U S A. 2009;106:7209-7214.
75. Cirrito JR, Yamada KA, Finn MB, et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron. 2005;48:913-922.
76. Vlassenko AG, Vaishnavi SN, Couture L, et al. Spatial correlation between brain aerobic glycolysis and amyloid-β (Aβ) deposition. Proc Natl Acad Sci U S A. 2010;107:17763-17767.
77. Vaishnavi SN, Vlassenko AG, Rundle MM, Snyder AZ, Mintun MA, Raichle ME. Regional aerobic glycolysis in the human brain. Proc Natl Acad Sci U S A. 2010;107:17757-17762.
78. Buckner RL. Human functional connectivity:new tools, unresolved questions. Proc Natl Acad Sci U S A. 2010;107:10769-10770.
79. Buckner RL. The role of the hippocampus in prediction and imagination. Annu Rev Psychol. 2010;61:27-48, C21-C28.
80. Horovitz SG, Braun AR, Carr WS, et al. Decoupling of the brain's default mode network during deep sleep. Proc Natl Acad Sci U S A. 2009;106:11376- 11381.
81. Kang JE, Lim MM, Bateman RJ, et al. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science. 2009;326:1005- 1007.
82. De Havas JA, Parimal S, Soon CS, Chee MW. Sleep deprivation reduces default mode network connectivity and anti-correlation during rest and task performance. Neuroimage. 2012;59:1745-1751.
83. Lehmann M, Madison CM, Ghosh PM, et al. Intrinsic connectivity networks in healthy subjects explain clinical variability in Alzheimer's disease. Proc Natl Acad Sci U S A. 2013;110:11606-11611.
84. Picchioni D, Horovitz SG, Fukunaga M, et al. Infraslow EEG oscillations organize large-scale cortical-subcortical interactions during sleep:a combined EEG/fMRI study. Brain Res. 2011;1374:63-72.
85. Picchioni D, Duyn JH, Horovitz SG. Sleep and the functional connectome. Neuroimage. 2013;80:387-396.
86. Chow HM, Horovitz SG, Carr WS, et al. Rhythmic alternating patterns of brain activity distinguish rapid eye movement sleep from other states of consciousness. Proc Natl Acad Sci U S A. 2013;110:10300-10305.
87. Moran M, Lynch CA, Walsh C, Coen R, Coakley D, Lawlor BA. Sleep disturbance in mild to moderate Alzheimer's disease. Sleep Med. 2005;6:347- 352.
88. Westerberg CE, Mander BA, Florczak SM, et al. Concurrent impairments in sleep and memory in amnestic mild cognitive impairment. J Int Neuropsychol Soc. 2012;18:490-500.
89. Ju YE, McLeland JS, Toedebusch CD, et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol. 2013;70:587-593.